Log in to save to my catalogue

Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab...

Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2645856693

Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis

About this item

Full title

Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis

Publisher

Singapore: Springer Nature Singapore

Journal title

International journal of hematology, 2022-09, Vol.116 (3), p.446-452

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

There have recently been a few case reports of cutaneous T-cell lymphomas following treatment of atopic dermatitis with dupilumab, which works binding to the interleukin (IL)-4 receptor and inhibiting the JAK/ STAT cascade located downstream of both IL-4 and IL-13. Here, we report the first case of Hodgkin lymphoma (HL) in a patient treated with du...

Alternative Titles

Full title

Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2645856693

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2645856693

Other Identifiers

ISSN

0925-5710

E-ISSN

1865-3774

DOI

10.1007/s12185-022-03330-y

How to access this item